Description
AFLURIA INFLUENZA VIRUS VACCINE
First action · last action
2013-06-26 · 2013-06-26
Transactions
1
First transaction's obligation
$98,100
Base + all options value (sum of deltas)
$98,100
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
2
SDVOSB flag on record
No
Parent IDV
VA797P13C0042
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2013-06-26+$98,100= $98,100
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2013-06-26 | +$98,100 | $98,100 | AFLURIA INFLUENZA VIRUS VACCINE |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI N6U7P2B9VHS5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24626N0645 | 246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS | $167,990 | FY2026 |
| 36C26026N0271 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $69,996 | FY2026 |
| 36C24526N0409 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $125,993 | FY2026 |
| 36C24526N0395 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $151,658 | FY2026 |
| 36C24526N0422 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $130,659 | FY2026 |
| 36C24526N0427 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $186,656 | FY2026 |
Other recipients under 6505 from 667-SHREVEPORT (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25614P3675 | PHARMACYCLICS, INC. | 667-SHREVEPORT | $24,429 | FY2014 |
| VA25613F2557 | CEPHEID | 667-SHREVEPORT | $297,043 | FY2013 |
| VA25612F1886 | EUSA PHARMA (USA), INC. | 667-SHREVEPORT | $4,362 | FY2012 |
| VA25612P1759 | CARDINAL HEALTH 414, LLC | 667-SHREVEPORT | $3,274 | FY2012 |
| VA25612J1572 | NOVARTIS VACCINES AND DIAGNOSTICS, INC. | 667-SHREVEPORT | $87,840 | FY2012 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25613F1296_3600_VA797P13C0042_3600 · retrieved 2026-09-26.